193 related articles for article (PubMed ID: 4151921)
21. [Pilot study on oxaflumazine, a new piperazinated phenothiazine].
Villeneuve A; Dogan K; Lachance R; Drolet A
Int J Clin Pharmacol; 1972 Aug; 6(3):246-55. PubMed ID: 4405378
[No Abstract] [Full Text] [Related]
22. [Comparison of the therapeutic effect of triperidol with perphenazine in schizophrenia].
Náhunek K; Hádlik J; Svestka J; Rodová A; Vanýsek J
Cesk Psychiatr; 1969 Oct; 65(5):281-9. PubMed ID: 5363280
[No Abstract] [Full Text] [Related]
23. Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
Kiev A; Güclü B; Kulkarni AS
Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517
[No Abstract] [Full Text] [Related]
24. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
Cesková E; Svestka J
Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
[TBL] [Abstract][Full Text] [Related]
25. [Haloperidol decanoate in replacing combinations of antipsychotic agents in the treatment of chronic schizophrenics].
Youssef HA
Acta Psiquiatr Psicol Am Lat; 1984 Dec; 30(4):297-304. PubMed ID: 6152573
[No Abstract] [Full Text] [Related]
26. Comprehesiven clinical studies with thiothixene.
Ban TA; Lehmann HE; Sterlin C; Climan M
Dis Nerv Syst; 1975 Sep; 36(9):473-7. PubMed ID: 240651
[No Abstract] [Full Text] [Related]
27. Schizophrenia and severe tardive dyskinesia responsive to risperidone.
Kopala LC; Honer WG
J Clin Psychopharmacol; 1994 Dec; 14(6):430-1. PubMed ID: 7533794
[No Abstract] [Full Text] [Related]
28. Relative efficacy of butaperazine and chlorpromazine in acute schizophrenia.
Gershon S; Hekimian LJ; Burdock EI; Park S; Floyd A
Curr Ther Res Clin Exp; 1970 Dec; 12(12):810-8. PubMed ID: 4396420
[No Abstract] [Full Text] [Related]
29. Haloperidol for chronically hospitalized psychotics: a double-blind comparison with thiothixene and placebo; a follow-up open evaluation.
Howard JS
Dis Nerv Syst; 1974 Oct; 35(10):458-63. PubMed ID: 17894059
[No Abstract] [Full Text] [Related]
30. [Comparison of triperidol with perphenazine in schizophrenic psychoses. Effect on the photomyoclonic threshold].
Náhunek K; Hádlík J; Rodová A; Misurec J; Vanýsek J
Act Nerv Super (Praha); 1970 Jan; 12(1):56-7. PubMed ID: 4907390
[No Abstract] [Full Text] [Related]
31. Sertindole: a review of clinical efficacy.
Kane JM
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S59-63; discussion S63-4. PubMed ID: 9690972
[TBL] [Abstract][Full Text] [Related]
32. Olfactory reference syndrome treated by blonanserin augmentation.
Takekita Y; Kato M; Sakai S; Suwa A; Nishida K; Tajika A; Yoshimura M; Kinoshita T
Psychiatry Clin Neurosci; 2011 Mar; 65(2):203-4. PubMed ID: 21414096
[No Abstract] [Full Text] [Related]
33. Longterm maintenance therapy with depot haloperidol in schizophrenia.
Zbytovský J
Homeost Health Dis; 1991; 33(5-6):287. PubMed ID: 18265499
[No Abstract] [Full Text] [Related]
34. Depressive symptoms and schizophrenia a psychopharmacological approach.
Mauri MC; Bravin S; Fabiano L; Vanni S; Boscati L; Invernizzi G
Encephale; 1995; 21(5):555-8. PubMed ID: 8529564
[TBL] [Abstract][Full Text] [Related]
35. A double blind controlled trial of thiothixene and perphenazine in chronic schizophrenics shown to require maintenance therapy.
Kellam AM; Jones KS
Acta Psychiatr Scand; 1971; 47(2):174-85. PubMed ID: 4947996
[No Abstract] [Full Text] [Related]
36. Antiparkinson drugs in paranoid schizophrenia.
Cavenar JO; Braasch ER; Sullivan JL
N C Med J; 1979 May; 40(5):287-8. PubMed ID: 35758
[No Abstract] [Full Text] [Related]
37. [On the problem of the general and elective action of psycholeptics in the therapy of schizophrenia].
Smulevich AB; Golovan' LI; Sokolova ED; Tsutsul'kovskaia MIa
Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(2):246-50. PubMed ID: 5655743
[No Abstract] [Full Text] [Related]
38. [On the question of differences between therapeutic responses after particular neuroleptics in comparison to perphenazine in schizophrenics (author's transl)].
Náhunek K; Svestka J; Cesková E
Cesk Psychiatr; 1981 Feb; 77(1):25-30. PubMed ID: 6113897
[No Abstract] [Full Text] [Related]
39. Switch to ziprazidone treatment is associated with changes in MMN amplitude: a case report.
Salazar J; Ordoño F; Soriano S; Rueda M; Ojeda E; Cozar R; Belloch V
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):573-4. PubMed ID: 19439243
[No Abstract] [Full Text] [Related]
40. [Natural evolution of paranoid schizophrenia treated consecutively with 4 different neuroleptics].
Portier A; Sarfati Y
Encephale; 2000; 26(4):75-7. PubMed ID: 11064844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
